48,830
edits
(→Papillary thyroid carcinoma: +subdivide) |
(→Graves disease: +Ab) |
||
Line 162: | Line 162: | ||
*Often misspelled "Grave's disease". | *Often misspelled "Grave's disease". | ||
*Autoimmune disease leading to hyperthyroidism. | *Autoimmune disease leading to hyperthyroidism. | ||
*Eye problems not resolved with thyroid removal. | *Eye problems not resolved with thyroid removal.{{fact}} | ||
*Higher risk of papillary thyroid carcinoma. | *Higher risk of [[papillary thyroid carcinoma]]. | ||
Clinical: | |||
*TSH-receptor antibody +ve.<ref name=pmid19576193>{{Cite journal | last1 = Massart | first1 = C. | last2 = Gibassier | first2 = J. | last3 = d'Herbomez | first3 = M. | title = Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay. | journal = Clin Chim Acta | volume = 407 | issue = 1-2 | pages = 62-6 | month = Sep | year = 2009 | doi = 10.1016/j.cca.2009.06.033 | PMID = 19576193 }}</ref> | |||
===Gross=== | ===Gross=== |
edits